11-1-2954 CSOBAs - U.S. Producer Questionnaire

Information collections for import injury investigations (producers, importers, purchasers, and foreign producer questionnaires and institution notices for 5-year reviews)

US Producer Questionnaire

Preliminary Investigations - April

OMB: 3117-0016

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 3117-0016 can be found here:

Document [pdf]

Download: pdf | pdf

OMB No. 3117-0016/USITC No. 11-1-2954; Expiration Date: 6/30/2011
(No response is required if currently valid OMB control number is not displayed)

U.S. PRODUCERS’ QUESTIONNAIRE
CERTAIN STILBENIC OPTICAL BRIGHTENING AGENTS (CSOBAs)
FROM CHINA AND TAIWAN

This questionnaire must be received by the Commission by no later than April 15, 2011
See page 4 of the Instruction Booklet for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its antidumping investigation(s) concerning CSOBAs from China and Taiwan (Inv. No. 731-TA-11861187 (Preliminary)). The information requested in the questionnaire is requested under the authority of the Tariff Act of
1930, title VII. This report is mandatory and failure to reply as directed can result in a subpoena or other order to
compel the submission of records or information in your possession (19 U.S.C. § 1333(a)).

Name of firm
Address
State

City

Zip Code

World Wide Web address
Has your firm produced CSOBAS (as defined in the instruction booklet) at any time since January 1, 2008?

(Sign the certification below and promptly return only this page of the questionnaire to the Commission)

YES

(Read the instruction booklet carefully, complete all parts of the questionnaire, and return the entire
questionnaire to the Commission so as to be received by the date indicated above)

CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my knowledge
and belief and understand that the information submitted is subject to audit and verification by the Commission.
By means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout this proceeding in any other import-injury proceedings conducted by
the Commission on the same or similar merchandise.
I acknowledge that information submitted in this questionnaire response and throughout this proceeding may be used by the
Commission, its employees, and contract personnel who are acting in the capacity of Commission employees, for developing or
maintaining the records of this proceeding or related proceedings for which this information is submitted, or in internal audits and
proceedings relating to the programs and operations of the Commission pursuant to 5 U.S.C. Appendix 3. I understand that all
contract personnel will sign non-disclosure agreements.

Name of Authorized Official

Title of Authorized Official
Phone: (

Date

)

Signature

E-mail address
Fax (

)

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1187-1187 (Preliminary))

Page 2

PART I.—GENERAL INFORMATION
The questions in this questionnaire have been reviewed with market participants to ensure that issues of
concern are adequately addressed and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to average 50 hours per response,
including the time for reviewing instructions, searching existing data sources, gathering the data needed,
and completing and reviewing the questionnaire. Send comments regarding the accuracy of this burden
estimate or any other aspect of this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade Commission, 500 E Street, SW,
Washington, DC 20436.
I-1a.

OMB statistics.--Please report below the actual number of hours required and the cost to your
firm of preparing the reply to this questionnaire and completing the form.
hours

dollars

I-1b.

OMB feedback.--We are interested in any comments you may have for improving this
questionnaire in general or the clarity of specific questions. Please attach such comments to your
response or send them to the above address.

I-2.

Establishments covered.--Provide the name and address of establishment(s) covered by this
questionnaire (see page 3 of the instruction booklet for reporting guidelines). If your firm is
publicly traded, please specify the stock exchange and trading symbol.

I-3.

Petition support.--Do you support or oppose the petition?
Support

Oppose

Take no position

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 3

PART I.--GENERAL INFORMATION--Continued
I-4.

Ownership.--Is your firm owned, in whole or in part, by any other firm?
No

Firm name

I-5.

Address

Extent of
ownership

Related importers/exporter.--Does your firm have any related firms, either domestic or foreign,
that are engaged in importing CSOBAS from CHINA and/or Taiwan into the United States or
that are engaged in exporting CSOBAS from the CHINA and/or Taiwan to the United States?
No
Firm name

I-6.

Yes--List the following information

Yes--List the following information
Address

Affiliation

Related producers.--Does your firm have any related firms, either domestic or foreign, that are
engaged in the production of CSOBAS?
No
Firm name

Yes--List the following information
Address

Affiliation

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 4

PART II.--TRADE AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Cynthia Trainor (202-2053354, [email protected]). Supply all data requested on a calendar-year basis.
II-1.

Please identify the individual to be contacted regarding the confidential information requested in
part II.
Name and title:
Please indicate the manner by which Commission staff may contact the individual responsible for
part II with questions regarding the submitted confidential information.
E-mail:
Fax: (

II-2.

Telephone: (

)

Changes in operations.--Please indicate whether your firm has experienced any of the following
changes in relation to the production of CSOBAs since January 1, 2008.
(check as many as appropriate)
(please describe)
plant openings ..........................

plant closings ............................

relocations ................................

expansions ................................

acquisitions ...............................

consolidations ...........................

prolonged shutdowns or
production curtailments .................
revised labor agreements ..........

other (e.g., technology) ............

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 5

PART II.--TRADE AND RELATED INFORMATION--Continued
II-3.

Same equipment, machinery, and workers.--Has your firm since 2008 produced, or does your
firm anticipate producing in the future, other products on the same equipment and machinery
used in the production of CSOBAs and/or using the same production and related workers
employed to produce CSOBAs?
No

Product

Yes--List the following information and report your firm’s combined
production capacity and production of these products and CSOBAs in
the periods indicated.

Period

Basis for allocation of capacity and
employment data (indicate if different)

Quantity in 1,000 dry pounds (100 percent active ingredient basis)
Item
Calendar years
2008
2009
Overall Production Capacity
Production of:
Subject CSOBAs
Fluorescent Brightener 71
All other optical brighteners
All other products
Quantity in 1,000 pounds (in solution)
Item
Calendar years
2008
2009
Overall Production Capacity
Production of:
Subject CSOBAs
Fluorescent Brightener 71
All other optical brighteners
All other products

2010

II-4.

Production constraints and product shifting.--Please describe the constraint(s) that set the limit(s)
on your production capacity and your ability to shift production capacity between products.

II-5.

Tolling.--Since January 1, 2008, has your firm been involved in a toll agreement (see definition
in the instruction booklet) regarding the production of CSOBAs?
No

Yes--Name firm(s):

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 6

PART II.--TRADE AND RELATED INFORMATION--Continued
II-6.

Foreign trade zone.--Does your firm produce CSOBAs in a foreign trade zone (FTZ)?
No

II-7.

Yes--Identify FTZ(s):

Importer.--Since January 1, 2008, has your firm imported CSOBAs?
No

Yes--COMPLETE AND RETURN A U.S. IMPORTERS’ QUESTIONNAIRE

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 7

PART II.--TRADE AND RELATED INFORMATION--Continued
II-8a.

Trade data.--Report your firm’s production capacity, production, shipments, inventories, and
employment related to the production of CSOBAs in your U.S. establishment(s) during the
specified periods. (See definitions in the instruction booklet.)
Quantity in 1,000 dry pounds (100 percent active ingredient basis) and Value in $1,000
Calendar years
Item

2008

2009

2010

Average production capacity1 (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Form of product shipments:
U.S. shipments in solution form (quantity)
U.S. shipments in powder form (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes
in reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you use a
different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value
data using that basis for each of the periods noted above:
3

Identify your principal export markets:
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-ofperiod inventories, plus production, less total shipments, equals end-of-period inventories. Do the data reported
reconcile?
Yes
No--Please explain:
Please advise the weighted average percentage of active ingredient contained:
2008:
; 2009:
2010:
4

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 8

PART II.--TRADE AND RELATED INFORMATION--Continued
II-8b.

Quantity in 1,000 pounds (in solution) and Value in $1,000
Item
Calendar years
2008
2009
2010
Average production capacity1 (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
2
Value of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Form of product shipments:5
U.S. shipments in solution form (quantity)
U.S. shipments in powder form (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1
The production capacity (see definitions in instruction booklet) reported is based on operating
hours per
weeks per year. Please describe the methodology used to calculate production capacity, and explain
week,
any changes in reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you
use a different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and
provide value data using that basis for each of the periods noted above:
3

Identify your principal export markets:
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows:
beginning-of-period inventories, plus production, less total shipments, equals end-of-period inventories. Do the
data reported reconcile?
4

Yes
No--Please explain:
Please advise the weighted average percentage of active ingredient contained:
2008:
; 2009:
2010:

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 9

PART II.--TRADE AND RELATED INFORMATION--Continued
II-9a.

Trade data.--Report your firm’s commercial shipments by category of CSOBAs from your U.S.
production in your U.S. establishment(s) during the specified periods. (See definitions in the
instruction booklet.)
Quantity in 1,000 dry pounds (100 percent active ingredient basis) and value in $1,000
Calendar years
Item

2008

2009

2010

U.S. commercial shipments of CSOBAs:1
Di-category:
Quantity of commercial shipments
Value of commercial shipments
Tetra-category:
Quantity of commercial shipments
Value of commercial shipments
Hexa-category:
Quantity of commercial shipments
Value of commercial shipments
All other categories of CSOBAs:
Quantity of commercial shipments
Value of commercial shipments
U.S. commercial shipments of Fluorescent
Brightener 71:
Quantity of commercial shipments
Value of commercial shipments
1

Reconciliation of data.--Please note that the total of the quantities and values reported by category should equal the
total quantity and value of commercial shipments reported in question II-8b. The total of the quantity and values
reported for CSOBAs plus fluorescent brightener 71 should equal the total quantity and value of commercial shipments
reported in question II-8a. Do the data reported reconcile?
Yes

No--Please explain:

Identify your principal export markets by category of CSOBA: Di:

; Tetra:

. Hexa:

Does your firm ship different forms (solution or powder) of CSOBAs by category (Di- versus Tetra- versus Hexacategory)?
No

Yes --Please explain:

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 10

PART II.--TRADE AND RELATED INFORMATION--Continued
II-9b.

Trade data.--Report your firm’s commercial shipments by category of CSOBAs from your U.S.
production in your U.S. establishment(s) during the specified periods. (See definitions in the
instruction booklet.)
Quantity in 1,000 pounds (in solution) and value in $1,000
Calendar years
Item

2008

2009

2010

No--Please explain:

Identify your principal export markets by category of CSOBA: Di:

; Tetra:

. Hexa:

Does your firm ship different forms (solution or powder) of CSOBAs by category (Di- versus Tetra- versus Hexacategory)?
No

Yes --Please explain:

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 11

PART II.--TRADE AND RELATED INFORMATION--Continued
II-10a. Trade data.--Report your firm’s production capacity, production, shipments, inventories, and
employment related to the production of CSOBAs plus Fluorescent Brightener 71 in your U.S.
establishment(s) during the specified periods. (See definitions in the instruction booklet.)
Quantity in 1,000 dry pounds (100 percent active ingredient basis) and value in $1,000
Calendar years
Item

2008

2009

2010

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 12

PART II.--TRADE AND RELATED INFORMATION--Continued
II-10b. Trade data.--Report your firm’s production capacity, production, shipments, inventories, and
employment related to the production of CSOBAs plus Fluorescent Brightener 71 in your U.S.
establishment(s) during the specified periods. (See definitions in the instruction booklet.)
Quantity in 1,000 pounds (in solution) and value in $1,000
Calendar years
Item

2008

2009

2010

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 13

PART II.--TRADE AND RELATED INFORMATION--Continued
II-11a. Trade data.--Report your firm’s commercial shipments by category of CSOBAs and
Fluorescent Brightener 71 from your U.S. production in your U.S. establishment(s) during the
specified periods. (See definitions in the instruction booklet.)
Quantity in 1,000 dry pounds (100 percent active ingredient basis) and value in $1,000
Calendar years
Item

2008

2009

2010

No--Please explain:

Identify your principal export markets by category of CSOBA: Di:

; Tetra:

. Hexa:

Does your firm ship different forms (solution or powder) of CSOBAs by category (Di- versus Tetra- versus Hexacategory)?
No

Yes --Please explain:

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 14

PART II.--TRADE AND RELATED INFORMATION--Continued
II-11b. Trade data.--Report your firm’s commercial shipments by category of CSOBAs and
Fluorescent Brightener 71 from your U.S. production in your U.S. establishment(s) during the
specified periods. (See definitions in the instruction booklet.)
Quantity in 1,000 pounds (in solution) and value in $1,000
Calendar years
Item

2008

2009

2010

No--Please explain:

Identify your principal export markets by category of CSOBA: Di:

; Tetra:

. Hexa:

Does your firm ship different forms (solution or powder) of CSOBAs by category (Di- versus Tetra- versus Hexacategory)?
No

Yes --Please explain:

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 15

PART II.--TRADE AND RELATED INFORMATION--Continued
II-12.

Related firms.--If you reported transfers to related firms in question II-8, please indicate the
nature of the relationship between your firm and the related firms (e.g., joint venture, wholly
owned subsidiary), whether the transfers were priced at market value or by a non-market formula,
whether your firm retained marketing rights to all transfers, and whether the related firms also
processed inputs from sources other than your firm.

II-13a. Purchases.--Other than direct imports, has your firm otherwise purchased CSOBAs since
January 1, 2007? (See definitions in the instruction booklet.)
Yes--Report such purchases below for the specified periods.1

Quantity in 1,000 dry pounds (100 percent active ingredient basis) and value in $1,000
Calendar years
Item

2008

2009

2010

PURCHASES FROM U.S. IMPORTERS2 OF CSOBAS FROM-CHINA:
Quantity
Value
TAIWAN
Quantity
Value
All other countries:
Quantity
Value
PURCHASES FROM DOMESTIC PRODUCERS:2
Quantity
Value
PURCHASES FROM OTHER SOURCES:2
Quantity
Value
1

Please indicate your reasons for purchasing this product. If your reasons differ by source, please elaborate.

Please list the name of the firm(s) from which you purchased this product. If your suppliers differ by source,
please identify the source for each listed supplier.

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 16

PART II.--TRADE AND RELATED INFORMATION--Continued
II-13b. Purchases.--Other than direct imports, has your firm otherwise purchased CSOBAs since
January 1, 2007? (See definitions in the instruction booklet.)
Yes--Report such purchases below for the specified periods.1

Quantity in 1,000 pounds (in solution) and value in $1,000
Calendar years
Item

2008

2009

2010

PURCHASES FROM U.S. IMPORTERS OF CSOBAS FROM-CHINA:
Quantity
Value
TAIWAN
Quantity
Value
All other countries:
Quantity
Value
PURCHASES FROM DOMESTIC PRODUCERS:2
Quantity
Value
PURCHASES FROM OTHER SOURCES:2
Quantity
Value
1

Please indicate your reasons for purchasing this product. If your reasons differ by source, please elaborate.

Please list the name of the firm(s) from which you purchased this product. If your suppliers differ by source,
please identify the source for each listed supplier.

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 17

PART III.--FINANCIAL INFORMATION
Address questions on this part of the questionnaire to Charles Yost (202-205-3432,
[email protected]).
III-1.

Please identify the individual to be contacted regarding the confidential information requested in
part III?
Name and title:
Please indicate the manner by which Commission staff may contact the individual responsible for
part III with questions regarding the submitted confidential information.
E-mail:

Telephone: (

Fax: (

)

III-2. General guidance:--Financial data are requested on a product-line basis that is CSOBAs according
to the definition of the product in the instruction booklet. Inputs your firm receives from affiliates to
produce CSOBAs should be stated at cost (i.e., intra-firm profits eliminated—see question III-7) while
transfers of CSOBAse to related affiliates should be stated at fair market value. Please report all sales on
an f.o.b. basis. Total sales in this section should equal total shipments plus exports in Part II Trade
information of this questionnaire
III-3.

Accounting system.--Briefly describe your financial accounting system.
A.

When does your fiscal year end (month and day)?
If your fiscal year changed during the period examined, explain below:

B.1.

Describe the lowest level of operations (e.g., plant, division, company-wide) for
which financial statements are prepared that include subject merchandise:

2.
3.

Does your firm prepare profit/loss statements for the subject merchandise:
Yes
No
How often did your firm (or parent company) prepare financial statements
(including annual reports, 10Ks)? Please check relevant items below.
Audited,
unaudited,
annual reports,
10Ks,
10 Qs,
Monthly,
quarterly,
semi-annually,
annually
GAAP,
cash,
tax, or
other comprehensive
Accounting basis:
(specify)

Note: The Commission may request that your company submit copies of its financial statements,
including internal profit-and-loss statements for the division or product group that includes
CSOBAs, as well as those statements and worksheets used to compile data for your firm’s
questionnaire response.

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 18

PART III.--FINANCIAL INFORMATION--Continued
III-4.

Cost accounting system.--Briefly describe your cost accounting system (e.g., standard cost, job
order cost, etc.).

III-5.

Allocation basis.--Briefly describe your allocation basis, if any, for COGS, SG&A, and interest
expense and other income and expenses.

III-6.

Other products.--Please list any other products you produced in the facilities in which you
produced CSOBAs, and provide the share of net sales accounted for by these other products in
your most recent fiscal year:
Products
Fluorescent Brightener 71
Other optical brighteners

Share of sales

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 19

PART III.--FINANCIAL INFORMATION--Continued
III-7a. Does your firm receive inputs (raw materials, labor, energy, or any other services) used in the
production of CSOBAs from any related firm?
Yes—Continue to question III-8b below.
No--Continue to question III-9 below.
III-7b. Inputs from related firms.--In the space provided below, identify the inputs used in the
production of CSOBAs that your firm receives from related parties.
Input

Related party

III-7c. Inputs from related firms at cost.--All intercompany profit on inputs purchased from related
parties that is eliminated pursuant to formal financial statement consolidation should also be
eliminated from the costs reported to the Commission in question III-10 (i.e., costs reported in
question III-10, to the extent that they reflect inputs purchased from related parties, should only
reflect the related party’s cost and not include an associated profit component). Reasonable
methods for determining and eliminating the associated profit on inputs purchased from related
parties are acceptable.
Has your firm complied with the Commission’s instructions regarding costs associated with
inputs purchased from related parties?
Yes
III-8.

No—Please contact Charles Yost (202-205-3432, [email protected]).

Nonrecurring charges.--For each annual period for which financial results are reported in
question III-9a and III-9b, please indicate in the schedule below the specific nonrecurring
charges, the particular expense/cost line items from question III-11 where the associated charges
are included, a brief description of the charges, and the associated values (in $1,000).
Nonrecurring charges would include, but are not limited to, items such as asset write-offs and
accelerated depreciation due to restructuring of the company’s CSOBAs operations.
Fiscal years ended-Item

Non-recurring charges: (In this column please provide a brief description of each nonrecurring charge and indicate the
particular expense/cost line items where the associated charges are included in question III-9.)
1. Description:

; classification:

2. Description:

; classification:

3. Description:

; classification:

4. Description:

; classification:

5. Description:

; classification:

6. Description:

; classification:

7. Description:

; classification:

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 20

PART III.--FINANCIAL INFORMATION--Continued
III-9a. Operations on CSOBAS.--Report the revenue and related cost information requested below on
the total CSOBAs operations of your U.S. establishment(s).1 Do not report resales of products.
Note that internal consumption and transfers to related firms must be valued at fair market value
and purchases from related firms must be at cost.2 Provide data for your three most recently
completed fiscal years in chronological order from left to right. If your firm was involved in
tolling operations (either as the toller or as the tollee) please contact Charles Yost at (202) 2053432 before completing this section of the questionnaire.
Quantity (in 1,000 dry pounds, 100 percent active ingredient basis) and value (in $1,000)
Fiscal years ended-Item
Net sales quantities:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please list the expense categories and amounts of any profits on internal inputs or inputs from related firms that are reflected on
your books but which are eliminated from the costs reported below.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II (question II-8a) of this questionnaire.
4
COGS should include costs associated with internal consumption and transfers to related firms.
2

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 21

PART III.--FINANCIAL INFORMATION--Continued
III-9b. Operations on CSOBAS.--Report the revenue and related cost information requested below on
the total CSOBAs operations of your U.S. establishment(s).1 Do not report resales of products.
Note that internal consumption and transfers to related firms must be valued at fair market value
and purchases from related firms must be at cost.2 Provide data for your three most recently
completed fiscal years in chronological order from left to right. If your firm was involved in
tolling operations (either as the toller or as the tollee) please contact Charles Yost at (202) 2053432 before completing this section of the questionnaire.
Quantity (in 1,000 pounds, in solution) and value (in $1,000)
Fiscal years ended-Item
Net sales quantities:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 22

PART III.--FINANCIAL INFORMATION--Continued
III-10a. Operations on CSOBAS and Fluorescent Brightener 71 combined.--Report the revenue and
related cost information requested below on the total CSOBAs plus Fluorescent Brightener 71
operations of your U.S. establishment(s).1 Do not report resales of products. Note that internal
consumption and transfers to related firms must be valued at fair market value and purchases
from related firms must be at cost.2 Provide data for your three most recently completed fiscal
years in chronological order from left to right. If your firm was involved in tolling operations
(either as the toller or as the tollee) please contact Charles Yost at (202) 205-3432 before
completing this section of the questionnaire.
Quantity (in 1,000 dry pounds,100 percent active ingredient basis) and value (in $1,000)
Fiscal years ended-Item
Net sales quantities:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 23

PART III.--FINANCIAL INFORMATION--Continued
III-10b. Operations on CSOBAS and Fluorescent Brightener 71 combined.--Report the revenue and
related cost information requested below on the total CSOBAs plus Fluorescent Brightener 71
operations of your U.S. establishment(s).1 Do not report resales of products. Note that internal
consumption and transfers to related firms must be valued at fair market value and purchases
from related firms must be at cost.2 Provide data for your three most recently completed fiscal
years in chronological order from left to right. If your firm was involved in tolling operations
(either as the toller or as the tollee) please contact Charles Yost at (202) 205-3432 before
completing this section of the questionnaire.
Quantity (in 1,000 pounds ,in solution) and value (in $1,000)
Fiscal years ended-Item
Net sales quantities:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 24

PART III.--FINANCIAL INFORMATION--Continued
III-11a. Operations on CSOBAs only.—For the costs reported in question III-9 of your U.S.
establishment(s), please provide breakouts of your raw material costs and energy and utility costs;
also estimate the ratio of fixed and variable costs to total costs in COGS and SG&A. Provide
data for your three most recently completed fiscal years in chronological order from left to right.
Value (in $1,000)
Fiscal years ended-Item
Raw material costs:
DAS
Aniline derivatives
All other raw materials
Energy and utility costs1
COGS:
Variable costs (percent)
Fixed costs (percent)
SG&A expenses:
Variable costs (percent)
Fixed costs (percent)
1

Please identify where energy and utility costs are classified in question III-11_______________________________.

III-11b. Operations on CSOBAs and Fluorescent Brightener 71 combined.—For the costs reported in
question III-10 of your U.S. establishment(s), please provide breakouts of your raw material
costs and energy and utility costs; also estimate the ratio of fixed and variable costs to total costs
in COGS and SG&A. Provide data for your three most recently completed fiscal years in
chronological order from left to right.
Value (in $1,000)
Fiscal years ended-Item
Raw material costs:
DAS
Aniline derivatives
All other raw materials
Energy and utility costs1
COGS:
Variable costs (percent)
Fixed costs (percent)
SG&A expenses:
Variable costs (percent)
Fixed costs (percent)
1

Please identify where energy and utility costs are classified in question III-11_______________________________.

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 25

PART III.--FINANCIAL INFORMATION--Continued
III-12a. Asset values.--Report the total assets associated with the production, warehousing, and sale of
CSOBAs only. If your firm does not maintain some or all of the specific asset data in the normal
course of business, please estimate it based upon some rational method (such as production, sales,
or costs) that is consistent with your cost allocations in the previous question. Your finished
goods inventory value should reconcile with the inventory quantity data reported in Part II.
Provide data as of the end of your three most recently completed fiscal years in chronological
order from left to right.
Value (in $1,000)
Fiscal years ended-Item
Assets associated with the production, warehousing, and
sale of CSOBAs:
1. Current assets:
A. Cash and equivalents
B. Accounts receivable, net
C. Finished goods inventories
D. Other (describe:

)

E. Total current assets (lines 1.A. through 1.D.)
2. Property, plant, and equipment
A. Original cost of property, plant, and equipment
B. Less: Accumulated depreciation
C. Equals: Book value of property, plant, and equipment
3. Other (describe:

)

4. Total assets (lines 1.E., 2.C., and 3)

III-12b. Asset values.--Report the total assets associated with the production, warehousing, and sale of
CSOBAS and Fluorescent Brightener 71 combined. Provide data as of the end of your three
most recently completed fiscal years in chronological order from left to right.
Value (in $1,000)
Fiscal years ended-Item
Assets associated with the production, warehousing, and
sale of CSOBAs:
1. Current assets:
A. Cash and equivalents
B. Accounts receivable, net
C. Finished goods inventories
D. Other (describe:

)

4. Total assets (lines 1.E., 2.C., and 3)

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 26

PART III.--FINANCIAL INFORMATION--Continued
III-13a. Capital expenditures and research and development expenses.--Report your firm’s capital
expenditures and research and development expenses on CSOBAs. Provide data for your three
most recently completed fiscal years in chronological order from left to right, and for the
specified interim periods.
Fiscal years ended-Item
Capital expenditures
Research and development expenses

III-13b. Capital expenditures and research and development expenses.--Report your firm’s capital
expenditures and research and development expenses on CSOBAS and Fluorescent Brightener
71 combined . Provide data for your three most recently completed fiscal years in chronological
order from left to right, and for the specified interim periods.
Fiscal years ended-Item
Capital expenditures
Research and development expenses

III-14. Effects of inputs.--Since January 1, 2008, has your firm experienced any actual negative effects
on its return on investment or its growth, investment, ability to raise capital, existing development
and production efforts (including efforts to develop a derivative or more advanced version of the
product), or the scale of capital investments as a result of imports of CSOBAs from China
and/or Taiwan?
No

Yes--My firm has experienced actual negative effects as follows:
China

Taiwan
Cancellation, postponement, or rejection of expansion projects
Denial or rejection of investment proposal
Reduction in the size of capital investments
Rejection of bank loans
Lowering of credit rating
Problem related to the issue of stocks or bonds
Other (specify; also specify whether CHINA or TAIWAN)

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAs (731-TA-1186-1187 (Preliminary))

Page 27

PART III.--FINANCIAL INFORMATION--Continued
III-15a. Anticipated effects of imports.--Does your firm anticipate any negative impact of imports of
CSOBAS from CHINA?

III-15b. Anticipated effects of imports.--Does your firm anticipate any negative impact of imports of
CSOBAS from TAIWAN?

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 28

PART IV.--PRICING AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Gerry Benedick (202-2053244, [email protected])

IV-1.

Please identify the individual to be contacted regarding the confidential information requested in
part IV.
Name and title:
Please indicate the manner by which Commission staff may contact the individual responsible for
parts IV with questions regarding the submitted confidential information.
E-mail:

Telephone:

Fax:
PRICE DATA
IV-2.

This section requests quarterly selling quantity and value data during January 2008-December
2010 for your firm’s U.S. commercial shipments of the following products that it produced
domestically and shipped in solution to U.S. paper-producing companies unrelated to your
firm by ownership.
Product 1.–4,4’-bis[4-[bis (2-hydroxyethyl) amino]-6-(4-sulfoanilino)-1,3,5-triazin-2-yl]amino2,2’-stilbenedisulfonic acid, C40H44N12O16S4 (“Fluorescent Brightener 220”)1 -For example:
Clariant’s Leucophor T-100 Liquid, T-105 Liquid, or T-4 Liquid;
BASF’s Tinopal ABP-A Liquid;
TFM’s Taflunol UMS T/P Powder or UMS 640L Liquid; and
Hongda’s 4PL-C, BBU-D, or Elcowhite TS.
Report Fluorescent Brightener 220 in solution, in bulk packaging (e.g., tank trucks, road tankers,
and/or rail cars);
Product 2.–Fluorescent Brightener 220 in solution, in non-bulk packaging (e.g., drums, totes,
and/or intermediate bulk containers).

Representative forms of this compound include the free acid form (CAS No. 3066-05-5), identified in the
product descriptions, as well as the tetrasodium salt form (CAS No. 16470-24-9).

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 29

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-2—Continued
Please note that the total quarterly sales values, on a shipment basis, should be reported two ways:
(1) Delivered to U.S. customers (paper companies)-Please report transactions on a delivered sales basis. The total quarterly quantities
should correspond to sales values shown on a delivered shipment basis. Total dollar figures
should reflect the FINAL NET amount paid to your firm (i.e., should be net of all deductions
for discounts, allowances, rebates, and the value of returned goods).
And, to the extent possible,
(2) Estimated f.o.b. U.S. plant(s), excluding all U.S.-inland freight, to U.S. customers (paper
companies)-Deduct from the delivered price (a) an estimate of U.S.-inland freight and shipping
charges from your U.S. shipping point(s) to the U.S. customers and (b) an estimate of any
U.S.-inland freight from your firm’s U.S. plant(s) to its non-plant U.S. shipping points, and
report the resulting estimated f.o.b. U.S. plant sales value. Please report transactions only
where your firm can report values on an (estimated) f.o.b. U.S. plant(s) sales basis.
The total quarterly quantities should correspond to sales values shown on estimated f.o.b.
U.S. plant(s) basis. Total dollar figures should reflect the FINAL NET return to your firm
(i.e., should be net of all deduction for discounts, allowances, rebates, absorbed freight, and
the value of returned goods).

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 30

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-2a. Pricing data(delivered value).—Please report below the quarterly price data for the specified
pricing products1 produced and sold by your firm as delivered in solution to U.S. paperproducing companies unrelated by ownership to your firm.

(Quantity in pounds, value in dollars)
Period of
shipment
2008:
Jan-Mar

Product 1
Quantity

Delivered Value

Product 2
2

Quantity

Delivered Value2

Apr-June
July-Sept
Oct.-Dec
2009:
Jan-Mar
Apr-June
July-Sept
Oct.-Dec
2010:
Jan-Mar
Apr-June
July-Sept
Oct.-Dec
1

Pricing product definitions are provided on the first page of Part IV.
Net values (i.e., gross sales values less all discounts, allowances, rebates, and the value of returned
goods), delivered to your U.S. customers.
2

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 31

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-2b. Pricing data (U.S. f.o.b. value).—Please report below the quarterly price data for the specified
pricing products1 produced and sold by your firm f.o.b. in solution to U.S. paper-producing
companies unrelated by ownership to your firm.

(Quantity in pounds, value in dollars)
Period of
shipment
2008:
Jan-Mar

Product 1
Quantity

Product 2
2

U.S. f.o.b. value

Quantity

U.S. f.o.b. value2

Apr-June
July-Sept
Oct.-Dec
2009:
Jan-Mar
Apr-June
July-Sept
Oct.-Dec
2010:
Jan-Mar
Apr-June
July-Sept
Oct.-Dec
1

Pricing product definitions are provided on the first page of Part IV.
Net values (i.e., gross sales values less all discounts, allowances, rebates, absorbed freight, and the value
of returned goods), f.o.b. your U.S. plant(s), estimated to exclude U.S.-inland freight.
2

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 32

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-3.

Price setting.-- How does your firm determine the prices that it charges for sales of its U.S.produced CSOBAs (check all that apply)?
Transaction by transaction

Contracts

Set price lists

Reverse internet auction sales
Other--Please describe:

IV-4.

Discount policy.-- Please indicate and describe your firm’s discount policies for sales of its U.S.produced CSOBAs (check all that apply).
Quantity discounts

Annual total volume discounts

No discounts

Other--Please describe:

IV-5.

IV-6.

Pricing terms for CSOBAs.-(a)

What are your firm’s typical sales terms for its U.S.-produced CSOBAs (e.g., 2/10 net 30
days)?
.

(b)

On what basis are your prices of its domestic CSOBAs usually quoted? (check one)
F.o.b.--Please specify point:
Delivered

Contract versus spot.--Approximately what share of your firm’s U.S. commercial shipment
value (f.o.b.) of its U.S.-produced CSOBAs in 2010 were on a (1) long-term contract basis
(multiple deliveries for more than 12 months), (2) short-term contract basis (multiple deliveries
up to and including 12 months), and (3) spot sales basis (for a single delivery)?

Type of sale
Long-term contracts
Short-term contracts
Spot sales

Share of U.S. commercial
shipment values in 2010
(percent)

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 33

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-7.

IV-8.

IV-9.

Long-term contract provisions.--If you sell on a long-term contract basis, please answer the
following questions with respect to provisions of a typical long-term contract.
(a)

What is the average duration of a contract?

(b)

Can prices be renegotiated during the contract period?

(c)

Does the contract fix quantity, price, or both?

(d)

Does the contract have a meet-or-release provision?

Yes

Quantity

Price
Yes

Both
No

Short-term contract provisions.--If you sell on a short-term contract basis, please answer the
following questions with respect to provisions of a typical short-term contract.
(a)

What is the average duration of a contract?

(b)

Can prices be renegotiated during the contract period?

(c)

Does the contract fix quantity, price, or both?

(d)

Does the contract have a meet-or-release provision?

Yes

Quantity

Price
Yes

Both
No

Lead times.--What is your share of your firm’s U.S. commercial shipment quantities in 2010
from inventory and produced to order and what is the average lead time between a customer’s
order and the date of delivery for your firm’s shipments of its U.S.-produced CSOBAs?

Source

Share of U.S.
commercial shipment
quantities in 2010

Lead time

From inventory
Produced to order
Total

100 %

IV-10. Shipping information.-(a)

What is the approximate average percentage of the total U.S. delivered price of your
firm’s U.S.-produced CSOBAs that is accounted for by U.S. inland transportation costs?
percent.

(b)

Who generally arranges the transportation to your customers’ locations? (check one)
Your firm or
purchaser

(c)

What proportion of your U.S. sales are delivered within 100 miles of your production
facility?
percent. Within 101 to 1,000 miles?
percent. Over 1,000 miles?
percent.

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 34

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-11. Geographical shipments.-- What is the geographic market area in the United States served by
your firm’s shipments of its U.S.-produced CSOBAs? (check all that apply)
Geographic area

√ if applicable

Northeast.–CT, ME, MA, NH, NJ, NY, PA, RI, and VT.
Midwest.–IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, and WI.
Southeast.–AL, DE, DC, FL, GA, KY, MD, MS, NC, SC, TN, VA, and WV.
Central Southwest.–AR, LA, OK, and TX.
Mountains.–AZ, CO, ID, MT, NV, NM, UT, and WY.
Pacific Coast.–CA, OR, and WA.
Other.–All other markets in the United States not previously listed, including AK, HI,
PR, VI, among others.

IV-12. End uses.--Describe the top three end uses of the CSOBAs that you manufacture. For each enduse product, what percentage of the total cost is accounted for by CSOBAS and other inputs?
Share of total cost of end use product
accounted for by
End use product

CSOBAs (percent)

Other inputs (percent)

Total

1.
100%
2.
100%
3.
100%

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 35

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-13. Substitutes.—
(a) Can other products be substituted for CSOBAs?
No

Yes--Please complete (b).

(b) Please list in order of importance any products that may be substituted for CSOBAs in the
U.S. market. For each possible substitute product, please describe the degree of
substitutability and indicate whether changes in the price of the substitute affect the price
and/or quantity for CSOBAs.

Substitute

End use(s) in which this
substitute is used

Have changes in the prices of this
substitute affected the price and/or
quantity for CSOBAs?

Yes--Please explain.

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 36

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-14. Demand trends.-(a)

How has the demand within the United States for CSOBAs changed since January 1,
2008? What principal factors affect changes in demand?
Increased

(b)

No Change

Decreased

Fluctuated

How has the demand outside the United States (if known) for CSOBAs changed since
January 1, 2008 What principal factors affect changes in demand?
Increased

No Change

Decreased

Fluctuated

IV-15. Product changes.--Have there been any significant changes in the product range, product mix, or
marketing (including sales over the internet) of CSOBAs since January 2008?
No

Yes--Please describe and quantify if possible.

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 37

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-16. Business cycles.-(a) Is the U.S. CSOBA market subject to business cycles or conditions of competition (including
seasonal business) distinctive to CSOBAs?
No (skip to question IV-17.)

Yes-- Please describe below and then answer part (b).

(b) If yes, have there been any changes in the business cycles or conditions of competition for
CSOBAs since January 1, 2008?
No

Yes-- Please describe.

IV-17. Supply constraints.--Has your firm refused, declined, or been unable to supply its U.S.-produced
CSOBAs since January 1, 2008 (examples include placing customers on allocation or “controlled
order entry,” declining to accept new customers or renew existing customers, delivering less than
the quantity promised, been unable to meet timely shipment commitments, etc.)?
No

Yes-- Please fill in the table.

Type of supply
constraint

When this
occurred

Which purchasers
were affected by the
constraint

Why did the supply
constraint occur

1.
2.
3.

IV-18. Raw materials.--Please describe any trends in the prices of raw materials used by your firm to
produce CSOBAs in the United States and whether your firm expects these trends to continue.

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 38

PART IV.--PRICING AND RELATED INFORMATION--Continued

IV-19. Interchangeability.--Are CSOBAs produced in the United States and in other countries
interchangeable in the U.S. market (i.e., can they physically be used in the same applications)?
Please indicate below, using “A” to indicate that the products from a specified country-pair are
always interchangeable, “F” to indicate that the products are frequently interchangeable, “S” to
indicate that the products are sometimes interchangeable, “N” to indicate that the products are
never interchangeable, and “0” to indicate no familiarity with products from a specified countrypair.1
Country-pair

China

Taiwan

Other countries

United States
China
Taiwan
1

For any country-pair producing CSOBAs that are sometimes or never interchangeable, please
explain the factors that limit or preclude interchangeable use (please identify any ‘other countries’):

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 39

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-20. Factors other than price.--Are differences other than price (i.e., quality, availability,
transportation network, product range, technical support, etc.) between CSOBAs produced in the
United States and in other countries a significant factor in your firm’s domestic sales of its U.S.produced products? Please indicate below, using “A” to indicate that such differences are always
significant, “F” to indicate that such differences are frequently significant, “S” to indicate that
such differences are sometimes significant, “N” to indicate that such differences are never
significant, and “0” to indicate no familiarity with products from a specified country-pair.1
Country-pair

China

Taiwan

Other countries

United States
China
Taiwan
1

For any country-pair for which factors other than price always or frequently are a significant factor in
your firm’s sales of its U.S.-produced CSOBAs, identify the country-pair and report the advantages or
disadvantages imparted by such factors (please identify any ‘other countries’):

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 40

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-21. Customer Identification--Please identify below the names and addresses of your firm’s
10 largest customers for its U.S.-produced CSOBAs during 2008-2010 (next to the company
name identify in parenthesis whether an end user (EU) or distributor (D)). Please also provide the
name and telephone number of a contact person and the share of the value (f.o.b.) of your firm’s
total U.S. commercial shipments of its U.S.-produced CSOBAs that each of these customers
accounted for in 2010.

No.

Customer’s name

Street address (not
P.O. box), city, state,
and zip code

Contact person and
e-mail address

Area
code and
telephone
number

Share of
2010
shipments
(%)

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 41

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-22. COMPETITION FROM IMPORTS--LOST REVENUES.--THIS SECTION IS TO BE
COMPLETED ONLY BY NON-PETITIONERS. (Note: petitioners may provide allegations
involving quotes made AFTER the filing of the petition.)
Since January 1, 2008: To avoid losing sales to competitors selling CSOBAs from China and/or
Taiwan, did your firm:
Reduce prices

Yes

Roll back announced price increases

Yes

If yes, please furnish as much of the following information as possible for each affected
transaction. Document such allegations of lost revenues whenever possible (documentation could
include copies of invoices, sales reports, or letters from customers). Please note that the
Commission may contact the firms named to verify the allegations reported.
Customer name, contact person, phone and fax numbers
Specific product(s) involved
Date of your initial price quotation
Quantity involved
Your initial rejected price quotation (total delivered value)
Your accepted price quotation (total delivered value)
The country of origin of the competing imported product
The competing price quotation of the imported product (total delivered value)
Customer name,
contact person,
phone and fax
numbers

Product

Date of
quote

Quantity
(pounds in
liquid form)

Initial
rejected U.S.
price (total
value-dollars)

Accepted
U.S. price
(total value-dollars)

Country of
origin

Competing
import price
(total
value—
dollars)

Business Proprietary
U.S. Producers’ Questionnaire – CSOBAS (731-TA-1186-1187 (Preliminary))

Page 42

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-23. COMPETITION FROM IMPORTS--LOST SALES.--THIS SECTION IS TO BE
COMPLETED ONLY BY NON-PETITIONERS. (Note: petitioners may provide allegations
involving quotes made AFTER the filing of the petition.)
Since January 1, 2008: Did your firm lose sales of CSOBAs to imports of these products from
China and/or Taiwan?
No

Yes

If yes, please furnish as much of the following information as possible for each affected
transaction. Document such allegations of lost sales whenever possible (documentation could
include copies of invoices, sales reports, or letters from customers). Please note that the
Commission may contact the firms named to verify the allegations reported.
Customer name, contact person, phone and fax numbers
Specific product(s) involved
Date of your price quotation
Quantity involved
Your rejected price quotation (total delivered value)
The country of origin of the competing imported product
The accepted price quotation of the imported product (total delivered value)
Customer name,
contact person,
phone and fax
numbers

Product

Date of
quote

Quantity
(pounds in
liquid form)

Rejected
U.S. price
(total value-dollars)

Country of
origin

Competing
import price
(total
value—
dollars)

File Type	application/pdf
File Title	Microsoft Word - Producer Questionnaire US OBA.doc
Author	cynthia.Trainor
File Modified	2011-04-05
File Created	2011-04-05